On the basis of our findings in 42 patients undergoing CABG surgery, we conclude that the recently introduced [TIMP-2] × [IGFBP-7] concentration–based NephroCheck test allows identification of patients at increased AKI risk after CS starting at the first postoperative day, but not during the early postoperative phase. This evidence concerns the gene IGFBP7 and acute kidney injury.